Snakebite: When the Human Touch Becomes a Bad Touch
- PMID: 29690533
- PMCID: PMC5923336
- DOI: 10.3390/toxins10040170
Snakebite: When the Human Touch Becomes a Bad Touch
Abstract
Many issues and complications in treating snakebite are a result of poor human social, economic and clinical intervention and management. As such, there is scope for significant improvements for reducing incidence and increasing patient outcomes. Snakes do not target humans as prey, but as our dwellings and farms expand ever farther and climate change increases snake activity periods, accidental encounters with snakes seeking water and prey increase drastically. Despite its long history, the snakebite crisis is neglected, ignored, underestimated and fundamentally misunderstood. Tens of thousands of lives are lost to snakebites each year and hundreds of thousands of people will survive with some form of permanent damage and reduced work capacity. These numbers are well recognized as being gross underestimations due to poor to non-existent record keeping in some of the most affected areas. These underestimations complicate achieving the proper recognition of snakebite’s socioeconomic impact and thus securing foreign aid to help alleviate this global crisis. Antivenoms are expensive and hospitals are few and far between, leaving people to seek help from traditional healers or use other forms of ineffective treatment. In some cases, cheaper, inappropriately manufactured antivenom from other regions is used despite no evidence for their efficacy, with often robust data demonstrating they are woefully ineffective in neutralizing many venoms for which they are marketed for. Inappropriate first-aid and treatments include cutting the wound, tourniquets, electrical shock, immersion in ice water, and use of ineffective herbal remedies by traditional healers. Even in the developed world, there are fundamental controversies including fasciotomy, pressure bandages, antivenom dosage, premedication such as adrenalin, and lack of antivenom for exotic snakebites in the pet trade. This review explores the myriad of human-origin factors that influence the trajectory of global snakebite causes and treatment failures and illustrate that snakebite is as much a sociological and economic problem as it is a medical one. Reducing the incidence and frequency of such controllable factors are therefore realistic targets to help alleviate the global snakebite burden as incremental improvements across several areas will have a strong cumulative effect.
Keywords: antivenom; envenomation; snakebite; venom.
Conflict of interest statement
The author declares no conflict of interest.
References
-
- Williams D.J., Gutierrez J.M., Calvete J.J., Wuster W., Ratanabanangkoon K., Paiva O., Brown N.I., Casewell N.R., Harrison R.A., Rowley P.D., et al. Ending the drought: New strategies for improving the flow of affordable, effective antivenoms in Asia and Africa. J. Proteom. 2011;74:1735–1767. doi: 10.1016/j.jprot.2011.05.027. - DOI - PubMed
-
- Williams D., Gutierrez J.M., Harrison R., Warrell D.A., White J., Winkel K.D., Gopalakrishnakone P., Global Snake Bite Initiative Working Group. International Society on Toxinology The Global Snake Bite Initiative: An antidote for snake bite. Lancet. 2010;375:89–91. doi: 10.1016/S0140-6736(09)61159-4. - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials